Litcius/Paper detail

Harmonisation of Pharmaceutical Take-Back Systems in the EU

Kateřina Mitkidis, Viktoria Obolevich, Polymeros Chrysochou, Panagiotis Mitkidis

2021European Journal of Health Law23 citationsDOIOpen Access PDF

Abstract

When medicines enter the environment, they harm living species and ecosystems. Improper disposal of household pharmaceutical waste increases the concentration of pharmaceuticals in the environment and thus their detrimental impacts. Since 2004, the EU has obliged its Member States to establish 'an appropriate collection system' for unused and/or expired medication. However, as no implementation guidelines exist, large differences in the systems and their use remain. Pressure for adoption of guidelines harmonising the systems across the EU has been increasing. We address the question whether such harmonisation could mitigate pharmaceutical pollution, and which regulatory measures would be appropriate. To answer this, we conduct a comparative investigation of the systems' regulation and an empirical study of citizens' beliefs and behaviour across four European countries. We find a potential for increasing the effectiveness of pharmaceutical take-back systems through their harmonisation and conclude that the EU has the competence and tools to regulate this.

Topics & Concepts

HarmBusinessMember statesCompetence (human resources)Environmental planningPublic economicsEuropean unionInternational tradePolitical scienceLawEconomicsEnvironmental scienceManagementPharmaceutical and Antibiotic Environmental ImpactsEffects and risks of endocrine disrupting chemicals
Harmonisation of Pharmaceutical Take-Back Systems in the EU | Litcius